• Blog
  • Transplant Diagnostics Market Report

    Transplant Diagnostics Market Report

    Transplant Diagnostics Market Report
    Report code - SRHL309 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Transplant Diagnostics Market Size, Share, Trend, Forecast, & Industry Analysis &ndash See more...

    Impact of COVID-19 on Transplant Diagnostics Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Transplant Diagnostics Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    Transplant diagnostics market is likely to witness an impressive CAGR of 7.4% during the forecast period. The demand for transplant diagnostics is driven mainly due to growing investments in target research activities, increasing infectious diseases, rising need for transplant procedures, and technological advancements in the field of healthcare.

    Transplant Diagnostics Market – Snapshot

    Growth

    7.4% for the next five years

    Major Technology  Type

    Molecular Assay Technologies

    Dominant Product & Service Type

    Reagent & Consumables

    Key Application Type

    Diagnostics Applications

    Major Transplant Type

    Solid Organ Transplantation

    Dominant End-User Type

    Hospital & Transplant Center

    Region with the highest demand

    North America

    Key Players

    Becton, Dickinson and Company, Biofortuna, Biomérieux SA,                  Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche Limited, Gendx, Hologic, Inc., Illumina, Inc., Immucor, Inc., Luminex Corporation,       Merck KGaA, Omixon, Qiagen Nv, and Thermo Fisher Scientific.

    Segment Analysis

    Transplant-Diagnostics-Market-Dominant-Segments

    Wish to get a free sample? Register Here

    Transplant Diagnostics Market Share: By Technology Type

    Based on the technology type, the market is segmented as molecular assay technologies and non-molecular assay technologies. The molecular assay technology segment held the larger share of the market in 2020, and is expected to remain dominant during the forecast period. The higher share is attributed to properties of molecular assay technologies such as higher procedural efficacy and real-time sample analysis.

    Transplant Diagnostics Market Share: By Product & Service Type

    Based on the product & service type, the market is segmented as instrument, reagent & consumables, and software. The reagent & consumable segment accounted for the largest share in 2020, owing to the frequency of usage and technological advancement in transplantation procedures. It is likely to dominate the market during the forecast period as well.

    Transplant Diagnostics Market Share: By Application Type

    Based on the application type, the market is segmented as diagnostic applications and research applications. The diagnostic applications segment accounted for the larger share of the market in 2020, owing to huge adoption of advanced molecular techniques for pathogen detection. The segment is expected to maintain its dominance during the forecast period as well.

    Transplant Diagnostics Market Share: By Transplant Type

    Based on the transplant type, the market is segmented as solid organ transplantation, stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation segment accounted for the largest share in 2020, on account of the rising incidences of cardiovascular, renal, lung and liver disease all across the globe.

    Transplant Diagnostics Market Share: By End-User Type

    Based on the end-user type, the market is segmented as independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The hospital & transplant centers segment captured the largest share of the market in 2020, and is likely to lead the market during the forecast period, owing to high patient footfall coupled with high budget of such healthcare facilities across the globe.

    Transplant Diagnostics Market Share: By Region

    In terms of regions, North America is projected to be the largest market for transplant diagnostics during the forecast period. The North American market is expected to expand with a lucrative CAGR due to the well-established medical device market, high healthcare expenditure, and huge demand majorly from the US.

    Transplant-Diagnostics-Market-By-Region

    Know which region offers best growth opportunities.Register Here

    Market Scope & Segmentation

    Diagnosis done by medical professionals for medical research regarding transplantation or in order to ensure whether or not a transplantation procedure is required falls under transplant diagnostics. Various medical instruments, reagents, and software are required for such diagnostics.

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market

    Transplant Diagnostics Market Research Report – Features

    Market Segmentation

    6

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    9

     

    The transplant diagnostics market is segmented into the following categories. 

    Transplant Diagnostics Market Size, Share, & Forecast, by Technology Type:

    • Molecular Assay Technologies  
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (Technology Type Analysis: PCR-based Molecular Assays and Sequencing-based Molecular Assays)
    • Non-Molecular Assay Technologies
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Transplant Diagnostics Market Size, Share, & Forecast, by Product & Service Type:

    • Instrument (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Reagent & Consumables (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Software (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Transplant Diagnostics Market Size, Share, & Forecast, by Application Type:

    • Diagnostic Applications
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (Application Type Analysis: Pre-Transplant Applications and Post-Transplant Applications)
    • Research Applications (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Transplant Diagnostics Market Size, Share, & Forecast, by Transplant Type:

    • Solid Organ Transplantation
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (Transplant Type Analysis: Kidney, Liver, Lung, Heart, Pancreas, and Others)
    • Stem Cell Transplantation (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Soft Tissue Transplantation (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Bone Marrow Transplantation (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Transplant Diagnostics Market Size, Share, & Forecast, by End-User Type:

    • Independent Reference Laboratories (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Hospitals & Transplant Centers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Research Laboratories & Academic Institutes (Regional Analysis: North America, Europe, Asia-Pacific, and RoW) 

    Transplant Diagnostics Market Size, Share, & Forecast, by Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Key Players

    Some of the major transplant diagnostic manufacturers are-

    • Becton
    • Dickinson and Company
    • Biofortuna
    • Biomérieux SA
    • Bio-Rad Laboratories
    • Caredx
    • F. Hoffman-La Roche Limited
    • Gendx
    • Hologic, Inc.
    • Illumina, Inc.
    • Immucor, Inc.
    • Luminex Corporation
    • Merck KGaA
    • Omixon
    • Qiagen Nv
    • Thermo Fisher Scientific.

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the technology types by application type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Technology portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The transplant diagnostics market is expected to witness an impressive growth of 7.4% CAGR in the foreseeable future.

    Becton, Dickinson and Company, Biofortuna, Biomrieux SA, Bio-Rad Laboratories, Caredx, F. Hoffman-La Roche Limited, Gendx, Hologic, Inc., Illumina, Inc., Immucor, Inc., Luminex Corporation, Merck KGaA, Omixon, Qiagen Nv, and Thermo Fisher Scientific are the key players in transplant diagnostics market.

    North America is expected to be the largest transplant diagnostics market during the forecast period.

    The hospital & transplant centers segment is expected to lead the transplant diagnostics market in the coming five years.

    The molecular assay technology segment is expected to remain dominant in the transplant diagnostics market during the forecast period.

    The diagnostic applications segment accounted for the larger share in the transplant diagnostics market in 2020.

    Growing investments in target research activities, increasing infectious diseases, rising need for transplant procedures, and technological advancements in the field of healthcare are the factors driving the growth of transplant diagnostics market.

    •